Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting


You May Also Like

Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date

The Meeting Seeking Stockholder Approval for Proposed Merger with Seelos Therapeutics, Inc. Will Be Reconvened ...